[1]
Haghighi, M., Sistanizad, M., Moradi, O., Goudarzi, M., Pourheidar, E., Tavakoli, N., Amiri, H. and Hosseini, M.S. 2022. Efficacy and safety of Interferon-beta 1a in the management of the outpatients with mild to moderate COVID-19 (A preliminary study). International journal of health sciences. 6, S7 (Oct. 2022), 6033–6041. DOI:https://doi.org/10.53730/ijhs.v6nS7.13420.